Seroprevalence of anti- C. trachomatis IgG and IgM antibodies Among Pregnant women in Diyala province
DOI:
https://doi.org/10.32007/jfacmedbagdad.554582Keywords:
C. trachomatis, anti-chlamydial IgG, anti-chlamydial IgMAbstract
Background: Chlamydia trachomatis infections are the most prevalent bacterial sexually transmitted infections (STI) recognized throughout the world. Screening programs for C. trachomatis is of paramount importance in the prevention of long-term sequelae.
Subjects and methods: A total of 91 normal healthy women were included in this study, which was conducted for the period from 1st. November/ 2011 to 1st. March 2012. They were chosen by simple random selection from Al-Batool Teaching Hospital for maternity and children, and some health care centers in Baquba city. The age range was 17-42 years. 49 (53.8%) and 42 (46.1%) were from rural and urban areas respectively. 77 (84.6%) of women with no previous abortion, and 14 (15.3%) with one or more abortions. 15 (16.5%) with no previous deliveries, and 76 (83.5%) had a number of children ranging from 1 to 7. The anti-chlamydia IgG and anti-chlamydia IgM antibodies were detected using ELISA technique. Statistical analysis was performed using SPSS version -15, and P - value of < 0.05 was considered significance.Objectives: To investigate the anti-chlamydia IgG and IgM seropositivity of healthy pregnant women in Baquba-Diyala province.
Results: The results revealed that the rate of anti-chlamydia IgG antibody among pregnant women was 5(5.5%), and 3 (3.3%) women were positive for anti-chlamydia IgM antibody. All anti-chlamydia IgM and the majority of anti-chlamydia IgG antibody positive women were belong to the age group 20-29 years. The anti-chlamydia IgM and IgG positivity rate has no association with residency, number of children, number of previous abortions, and the duration of pregnancy.
Conclusion: The rate of C. trachomatis infection among healthy pregnant women in diyala province was low.
Downloads
Downloads
Published
Issue
Section
License
Permit others to copy and distribute the manuscript; to extract, revise, and create another derivative
works of or from the manuscript (e.g., a translation); to incorporate the manuscript into a
collective work; and to text or data mine the article, even for commercial purposes, provided that
the author(s) is/are credited; the article's modifications should not harm the author's honor or
reputation; and the article should not be altered in a way that would cause the author to lose them
reputation. The Creative Commons Attribution 4.0 International License (CC BY 4.0) has more
information.